GPT Healthcare Q2 FY27 Revenue Up 15.2% to ₹138.6 Crore, PAT Surges 45.2%
GPT Healthcare reported Q2 FY27 revenue of ₹138.6 crore, up 15.2% YoY. PAT surged 45.2% to ₹15.4 crore. For H1 FY27, revenue was ₹266.8 crore (up 16.5%) and PAT was ₹28.1 crore (up 53.9%). Occupancy improved to 50.3% in Q2 FY27. Jamshedpur hospital completion expected by Q4 FY27.
The announcement details strong financial performance with substantial growth in revenue and profit, alongside positive operational metrics and the progress of new hospital development. This indicates a significant positive development for the company.
The company reported significant year-on-year growth in total income and profit after tax for both the quarter and half-year periods. Operational improvements such as increased occupancy and ARPOB, along with progress on new facilities, contribute to a positive outlook.
GPT Healthcare Limited reported its unaudited financial results for the second quarter and half year ended September 30, 2026. The company announced a total income of ₹138.6 crore for Q2 FY27, marking a 15.2% year-on-year growth from ₹120.2 crore in Q2 FY26. Profit After Tax (PAT) for the quarter surged by 45.2% to ₹15.4 crore, compared to ₹10.6 crore in the same period last year. The EBITDA for Q2 FY27 stood at ₹29.8 crore, a 23.9% increase year-on-year.
For the half year ended September 30, 2026 (H1 FY27), GPT Healthcare reported a total income of ₹266.8 crore, an increase of 16.5% compared to ₹228.9 crore in H1 FY26. PAT for H1 FY27 rose by an impressive 53.9% to ₹28.1 crore from ₹18.3 crore in the previous year. EBITDA for H1 FY27 was ₹56.0 crore, up 30.3% year-on-year.
Operationally, the company maintained a competitive Average Revenue Per Operating Bed (ARPOB) of ₹40,721 in Q2 FY27, showing a 7.1% YoY growth. Hospital occupancy improved to 50.3% across the network, including the new Raipur facility. The EBITDA margin improved by 150 basis points YoY to 21.5% in Q2 FY27 and expanded by 221 basis points to 21.0% for H1 FY27. The company highlighted significant medical milestones, including over 750 renal transplants across ILS Dum Dum and ILS Raipur, nearing 100 robotics procedures at ILS Howrah, over 3200 radiation therapy procedures at ILS Agartala, and surpassing 850 robotic surgeries at ILS Salt Lake. The Jamshedpur hospital is on track for completion by Q4 FY27.
Commenting on the performance, GPT Healthcare Chairman, Dr. Om Tantia, stated that the company delivered strong performance supported by disciplined execution and improving operational metrics. He noted that total income grew 16.5% YoY driven by resilient performance across established facilities and the ramp-up of newer hospitals. Network occupancy improved to 47.9% in H1 FY27 from 44.7% in H1 FY26. Inpatient revenue grew by 16.4% YoY, while outpatient revenue increased by 13.5% YoY. ARPOB increased by 8.1% YoY to ₹41,490. The company plans to focus on unlocking operating leverage, expanding its footprint, strengthening clinical capabilities, and adopting an asset-light expansion model.
What to do with a filing like this
GPT Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by GPT Healthcare Limited. Read the original for the full detail.